special interest O n Jun. 17, 2008, the lipid research community lost a beloved friend and scholar, Roger A. Davis. Roger was a major contributor to our understanding of the regulation of lipoprotein production, bile acid metabolism, and atherosclerosis.
Roger gravitated to science at an early age; he loved to tinker and felt that the truthfulness of science provided a refuge from the conflicting religious orthodoxies between the two sides of his family. During his senior year of high school in Wilmington, Delaware, he befriended prominent DuPont chemist Howard Simmons, who taught Roger how to smoke cigars, drink scotch, and perhaps most importantly, love organic chemistry. Roger took to Simmons' teachings, as he pursued chemistry for both his undergraduate and graduate degrees. After earning his doctorate in organic chemistry at Washington State University, he studied the biophysical aspects of bile acids in Fred Kern's laboratory at the University of Colorado. But, it was in Dan Steinberg's laboratory at UCSD where he first fell in love with biology and began what would become a lifelong involvement in the assembly and secretion of apolipoprotein B-containing lipoproteins.
Throughout his career, Roger, who served on the faculties of Louisiana State University, University of Colorado, and San Diego State University, exuded an insatiable curiosity that led to his unusually broad view of important biological problems. Although he liked to refer to himself as a chemist working in biology, his interests encompassed diverse fields including nutrition, metabolism, immunology, and genetics, and he was not afraid to employ techniques from each of these areas.
One of Roger's most influential discoveries occurred in 1987 when he found that a substantial fraction of synthesized apoB was actually degraded somewhere along the secretory pathway. In fact, the amount of secreted apoB is determined by the amount rescued from degradation. 1 In elegantly constructed and technically challenging experiments, Roger then demonstrated that critical segments of the apoB molecule require an interaction with microsomal triglyceride transfer protein (MTP) to be translocated across the ER membrane. 2 He also demonstrated that apoB secretion was highly sensitive to MTP but not to free fatty acids or triglycerides. 3 Of note, these significant findings preceded the appreciation of proteasomal and ER-associated degradation, now very active research fields in their own right.
Roger was prescient in other areas as well; as early as 1983, he showed that, contrary to widespread scientific belief, bile acids do not exert direct feedback inhibition on bile acid synthesis. which in turn mediates the indirect feedback on hepatic bile acid production through a signaling pathway involving the suppression of Cyp7A in the liver. [6] [7] [8] [9] Roger also showed, prior to the discovery of LXR, that cholesterol is a positive effector of bile acid synthesis. 5 One of Roger's greatest interests was developing new therapeutic approaches. He reasoned that hepatic macrophages (Kupffer cells) could provide a useful vehicle for delivery of protective genes in the liver, which has unrestricted contact with the blood. To test this principle, he created transgenic mice expressing the atherosclerosisprotective enzyme paraoxonase-1, and transplanted their marrow into hyperlipidemic recipient mice treated with gadolinium chloride (to destroy their endogenous Kupffer cells). This clever strategy resulted in a dramatic reduction of atherosclerotic lesions. 10 In recent years, Roger focused his attention on the role of thioredoxin interacting protein (txnip) in metabolism. Studying txnip knockout mice, Roger found that this gene plays a key role in mitochondrial function in muscle. In a landmark study, and his last research publication, Roger showed that mice deficient in muscle txnip have a profound defect in fatty acid and ketone body oxidation and a dramatic increase in insulin sensitivity; the latter phenotype was associated with a suppression of PTEN and argued that this was a consequence of an altered NAD + / NADH ratio. 11 Roger was passionate about this new direction and shortly before his death, obtained an NIH grant for this project.
Roger brought his passion for science to his battle with prostate cancer. He was simultaneously fascinated and frightened by his illness. He studied it and devised several novel therapies, all of which were attempted. And, perhaps due to his interventions, he lived far longer than his doctors predicted.
Roger was deeply devoted to his wife of 36 years, Kathy, his daughter, Kimmie, and his son, Harley. He enjoyed having intimate gatherings with friends and was especially proud of his Louisiana gumbo and jambalaya. He enjoyed sailing, golf, and was a lifelong avid motorcycle rider, with a special fondness for Harley-Davidson bikes.
Roger had an extraordinary capacity for friendship. He developed a wide network of lifelong friends from all walks of life and continually nurtured those friendships with his warmth, wit, companionship, and joie de vivre. Within his scientific milieu, he was deeply appreciated for his razor-sharp judgment, his inclination to stimulate critical discussions, and his ability to speak with scientific authority without ever being pretentious or pedantic. His love of science emanated from his belief in its integrity and authenticity. He had low tolerance for scientists who exaggerated or oversold their data. His sardonic, sometimes corny wit, his hilarious puns, and his ability to make us take ourselves less seriously added much-needed levity to scientific conferences, committee meetings, and Journal of Lipid Research Editorial Board meetings. We all miss him terribly. 
